| 000 | 05900cam a2200769Ii 4500 | ||
|---|---|---|---|
| 005 | 20250919085810.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 161221s2015 enka ob 001 0 eng d | ||
| 020 |
_a9780128014714 _q(electronic bk.) |
||
| 020 |
_a0128014717 _q(electronic bk.) |
||
| 020 | _z9780128013175 | ||
| 029 | 1 |
_aCHBIS _b010547903 |
|
| 029 | 1 |
_aCHVBK _b341783668 |
|
| 029 | 1 |
_aDEBSZ _b451526465 |
|
| 029 | 1 |
_aGBVCP _b829920315 |
|
| 029 | 1 |
_aNLGGC _b393524787 |
|
| 029 | 1 |
_aNZ1 _b16092610 |
|
| 029 | 1 |
_aDEBBG _bBV043216385 |
|
| 035 |
_a(OCoLC)910159094 _z(OCoLC)910447567 |
||
| 035 | _a(OCoLC)ocn910159094 | ||
| 039 | 9 |
_y12-21-2016 _zhafiz _wmetacoll.MYUKM.updates.D20160920.T210208.sdallbooks.1 (perolehan)hafizupload21122016.mrc _x159 |
|
| 040 |
_aNST _beng _erda _epn _cNST _dIDEBK _dNST _dOPELS _dYDXCP _dEBLCP _dCDX _dABH _dDEBSZ _dOCLCQ _dNST |
||
| 049 | _aMAIN | ||
| 050 | 4 | _aRC113.3 | |
| 072 | 7 |
_aHEA _x039040 _2bisacsh |
|
| 072 | 7 |
_aMED _x022090 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.90475 _223 |
| 245 | 0 | 0 |
_aNanotechnology in diagnosis, treatment and prophylaxis of infectious diseases / _cedited by Mahendra Rai, Kateryna Kon. |
| 264 | 1 |
_aLondon : _bAcademic Press is an imprint of Elsevier, _c[2015] |
|
| 300 |
_a1 online resource : _billustrations (some color) |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aFront Cover; Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases; Copyright Page; Contents; List of Contributors; Preface; 1 Gold and Silver Nanoparticles for Diagnostics of Infection; 1.1 Nanotechnology and Infection; 1.2 Gold and Silver NPs for Molecular Diagnostics; 1.2.1 Biomarkers; 1.3 Nanodiagnostics for Nucleic Acids; 1.3.1 Homogeneous Colorimetric Assays; 1.3.1.1 Unmodified NPs; 1.3.1.2 Cross-Linking; 1.3.1.3 Noncross-Linking; 1.3.2 Heterogeneous Detection; 1.3.2.1 Microarrays; 1.3.2.2 Lateral Flow Assays; 1.3.3 Electrochemical Assays. | |
| 505 | 8 | _a1.3.4 Fluorescence Assays1.3.5 Raman and SERS; 1.3.6 Other; 1.4 Aptamers and Antibodies; 1.4.1 Colorimetric; 1.4.2 Electrochemical; 1.4.3 Lateral Flow Assays; 1.5 iPCR and Other Methods; 1.6 Conclusion; References; 2 Antimicrobial Models in Nanotechnology: From the Selection to Application in the Control and Treatment of Infectious Diseases; 2.1 Introduction; 2.2 Antimicrobial Susceptibility Testing Methods of NMs; 2.2.1 Broth Dilution Test; 2.2.2 Spectrophotometric Measurement; 2.2.3 Cell Counting; 2.2.4 Colorimetric and Fluorescent Assays; 2.2.5 In Vitro Infection Animal Model. | |
| 505 | 8 | _a2.2.6 Biocidal Testing2.2.7 Antibiofilm Activity; 2.2.8 Quorum-Sensing Inhibitors; 2.2.9 Microbial Membrane Lysis; 2.2.10 Microbial Oxidative Stress; 2.2.11 Antipersister and Antidormancy Bacterial Cells; 2.2.12 Microbial Fitness; 2.3 Nanotoxicology; 2.3.1 Nano-Genotoxicology; 2.3.2 Cytotoxicity; 2.3.3 Immunotoxicity; 2.3.4 In Vitro Skin Irritation; 2.3.5 Caenorhabditis elegans Toxicity Model; 2.3.6 Nanotoxicity in Embryonic and Adult Zebrafish; 2.3.7 Bioluminescence-Based Nanotoxicity Test; 2.4 In Vitro Pharmacokinetics/Pharmacodynamic Models; 2.4.1 Particokinetics; 2.4.2 Caco-2 Permeability. | |
| 505 | 8 | _a2.4.3 Hollow Fiber System2.5 Conclusions; References; 3 Silver Nanoparticles for the Control of Vector-Borne Infections; 3.1 Introduction; 3.2 Louse-Borne Infections and Activity of AgNPs Against Lice; 3.3 Mosquito-Borne Infections and Activity of AgNPs Against Mosquitoes; 3.4 Tick-Borne Infections and Activity of AgNPs Against Ticks; 3.5 Flies, Their Role in Transmission and Spread of Infections, and Activity of AgNPs Against Flies; 3.6 Conclusions and Future Prospects; References; 4 Magnetite Nanostructures: Trends in Anti-Infectious Therapy; 4.1 Introduction. | |
| 505 | 8 | _a4.2 Nanoparticles with Biomedical Applications4.2.1 Design of Tailored Magnetic Nanoparticles with Applications in Microbiology; 4.2.2 Magnetite Nanoparticles Used to Control Microorganisms Attachment and Biofilm Formation; 4.2.3 The Biocompatibility of Magnetite Nanoparticles; 4.2.3.1 Biocompatibility Evaluation of Magnetite Nanoparticles at the Cellular Level; 4.2.3.2 Biocompatibility Evaluation of Magnetite Nanoparticles at Biochemical and Molecular Level; 4.2.3.3 Biocompatibility Evaluation of Magnetite Nanoparticles Using Animal Models; 4.3 Conclusions; References. | |
| 588 | 0 | _aOnline resource; title from PDF title page (Ebsco, viewed May 29, 2015). | |
| 590 |
_aElsevier _bScienceDirect All Books |
||
| 650 | 0 |
_aCommunicable diseases _xDiagnosis _xTechnological innovations. |
|
| 650 | 0 |
_aCommunicable diseases _xTreatment _xTechnological innovations. |
|
| 650 | 0 | _aNanomedicine. | |
| 650 | 1 | 2 |
_aNanotechnology _xmethods. |
| 650 | 2 | 2 |
_aCommunicable Disease Control _xmethods. |
| 650 | 2 | 2 |
_aCommunicable diseases _xDiagnosis. |
| 650 | 2 | 2 |
_aCommunicable Diseases _xtherapy. |
| 650 | 2 | 2 | _aDrug Resistance, Microbial. |
| 650 | 4 | _aAntibiotics. | |
| 650 | 4 |
_aBacterial diseases _xChemotherapy. |
|
| 650 | 4 | _aNanomedicine. | |
| 650 | 7 |
_aHEALTH & FITNESS _xDiseases _xContagious. _2bisacsh |
|
| 650 | 7 |
_aMEDICAL _xInfectious Diseases. _2bisacsh |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aRai, Mahendra, _eeditor. |
|
| 700 | 1 |
_aKon, Kateryna Volodymyrivna, _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _aRai, Mahendra. _tNanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases. _dBurlington : Elsevier Science, ò015 _z9780128013175 |
| 856 | 4 | 0 | _uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=http://www.sciencedirect.com/science/book/9780128013175 |
| 907 |
_a.b1640077x _b2022-11-02 _c2019-11-12 |
||
| 942 | _n0 | ||
| 914 | _avtls003614182 | ||
| 998 |
_ae _b2016-08-12 _cm _dz _feng _genk _y0 _z.b1640077x |
||
| 999 |
_c613463 _d613463 |
||